MAXCYTE, INC. (MXCT)

↓ Download CSV

CIK 0001287098 · Nasdaq · Services-Commercial Physical & Biological Research

  • Sector Services
  • Incorporated DE
  • Fiscal year ends Dec 31

In fiscal 2025, MAXCYTE, INC. reported revenue of $20.96M, down 5.7% from the prior year. The company ran a net loss, with a net margin of -213.0% and a gross margin of 127.9%. It held $202.51M in total assets against $31.02M in total liabilities.

Key ratios (FY2025)

127.9%
Gross margin
-247.6%
Operating margin
-213.0%
Net margin
-26.0%
Return on equity
-5.7%
Revenue growth (YoY)
Metric (FY)20252024202320222021202020192018
Revenue$20.96M$22.21M$19.50M$28.75M$21.57M$15.45M$13.26M
Cost of Revenue$6.22M$7.10M$4.74M$5.10M$3.65M$2.77M$2.50M
Gross Profit$26.80M$31.53M$36.55M$39.16M$30.25M$23.40M$19.12M
Operating Income-$51.90M-$51.20M-$48.30M-$27.36M-$18.19M-$11.06M-$12.42M
Net Income-$44.63M-$41.05M-$37.92M-$23.57M-$19.08M-$11.82M-$12.89M
EPS (Diluted)$-0.42$-0.39$-0.37$-0.23$-0.21$-0.17$-0.23
Total Assets$202.51M$239.47M$268.27M$286.65M$284.12M$51.78M
Total Liabilities$31.02M$33.22M$36.11M$32.69M$21.22M$18.55M
Shareholders' Equity$171.49M$206.25M$232.17M$253.97M$262.90M$33.23M$13.60M$12.28M
Cash & Equivalents$20.07M$27.88M$46.51M$11.06M$47.78M$18.76M
Operating Cash Flow-$34.41M-$27.61M-$21.69M-$14.78M-$10.68M-$8.78M-$8.80M
Capital Expenditures$1.77M$1.65M$3.70M$18.48M$3.83M$2.07M$1.27M
Shares Outstanding106.43M104.85M103.27M101.70M90.62M69.46M56.40M